News

The deal will see the development and scale-up of a new affinity resin and associated manufacturing process to improve the quality and purity of an existing biopharmaceutical product

The multicenter, randomized, placebo-controlled Phase II trial will evaluate the efficacy and safety of letermovir for the prevention of clinically-significant CMV infection in adult 18 years and older.

MGD007 is a Dual-Affinity Re-Targeting (DART) protein in development to treat colorectal cancer. The company will receive a $5m milestone payment from Servier, France’s largest privately-held pharmaceutical company,

The FDA concluded that the company’s testosterone product is therapeutically equivalent to AbbVie’s AndroGel 1% and can be substituted with the full expectation that it will produce the

Flonase is the first and only OTC nasal spray indicated for relief of all nasal and eye-related allergy symptoms, including runny nose, sneezing, itchy nose, nasal congestion and

The contract supports the development of drugs to treat HIV and AIDS and the complications and opportunistic infections associated with the disease, as well as microbicides for preventing

Upon issuance, the U.S. Patent entitled, "Process for Producing a Composition Containing Active Follistatin," will provide intellectual property protection for making the key ingredient in MYOS’ core commercial

Abbott (ABT), the makers of Similac and experts in infant nutrition for nearly 90 years, studied the diets of more than 80 lactating women to assess how their

Formerly a division of Richmond, VA-based Alliance Engineering, Alliance Biosciences was the leading biosafety and biosecurity consulting firm in the United States. With this addition, WCG’s biosafety division